tiprankstipranks
Advertisement
Advertisement

CGEM Stock Latest News

Cullinan Therapeutics Shareholders Back Directors and Governance Measures
Company AnnouncementsCullinan Therapeutics Shareholders Back Directors and Governance Measures
20d ago
8K
CGEM
Cullinan Therapeutics price target raised to $46 from $33 at Clear Street
PremiumThe Fly
Cullinan Therapeutics price target raised to $46 from $33 at Clear Street
26d ago
CGEM
Cullinan Therapeutics Highlights Positive Early Autoimmune Trial Data
PremiumCompany Announcements
Cullinan Therapeutics Highlights Positive Early Autoimmune Trial Data
27d ago
8K
CGEM
Cullinan Therapeutics reports CLN-978, velinotamig data
PremiumThe Fly
Cullinan Therapeutics reports CLN-978, velinotamig data
27d ago
CGEM
Buy Rating on Cullinan Reinforced by Encouraging Early CLN-978 Autoimmune Data and High Upside Potential
PremiumRatings
Buy Rating on Cullinan Reinforced by Encouraging Early CLN-978 Autoimmune Data and High Upside Potential
28d ago
CGEM
Cullinan Showcases Promising CLN-978 Phase 1 Autoimmune Data
PremiumCompany AnnouncementsCullinan Showcases Promising CLN-978 Phase 1 Autoimmune Data
29d ago
8K
CGEM
Cullinan Therapeutics Reiterated as Buy on Promising CLN-978 Data; $30 Price Target Maintained
Premium
Ratings
Cullinan Therapeutics Reiterated as Buy on Promising CLN-978 Data; $30 Price Target Maintained
29d ago
CGEM
Cullinan Therapeutics presents clinical data for CLN-978
Premium
The Fly
Cullinan Therapeutics presents clinical data for CLN-978
29d ago
CGEM
Cullinan’s CLN-978 Lupus Study Opens a New Autoimmune Path for CGEM Investors
PremiumCompany Announcements
Cullinan’s CLN-978 Lupus Study Opens a New Autoimmune Path for CGEM Investors
1M ago
CGEM
Cullinan to host Immunology Day event, announce data for CLN-978, Velinotamig
PremiumThe Fly
Cullinan to host Immunology Day event, announce data for CLN-978, Velinotamig
1M ago
CGEM
Cullinan post-EULAR share pullback ‘unwarranted,’ says Clear Street
PremiumThe Fly
Cullinan post-EULAR share pullback ‘unwarranted,’ says Clear Street
2M ago
CGEM
Cullinan Therapeutics receives orphan drug designation for CLN-049
PremiumThe Fly
Cullinan Therapeutics receives orphan drug designation for CLN-049
2M ago
CGEM
Cullinan Management Shares Promising Early CLN-978 Autoimmune Data
PremiumCompany AnnouncementsCullinan Management Shares Promising Early CLN-978 Autoimmune Data
2M ago
8K
CGEM
Cullinan Therapeutics price target raised to $37 from $36 at Wedbush
Premium
The Fly
Cullinan Therapeutics price target raised to $37 from $36 at Wedbush
2M ago
CGEM
Cullinan Therapeutics reports Q1 EPS (75c), consensus (85c)
Premium
The Fly
Cullinan Therapeutics reports Q1 EPS (75c), consensus (85c)
2M ago
CGEM
Cullinan jumps after UCB acquires Candid Therapeutics
PremiumThe Fly
Cullinan jumps after UCB acquires Candid Therapeutics
2M ago
CGEM
Cullinan Oncology: FDA Acceptance of Zipalertinib NDA and Upcoming CLN-978 Data Underpin Buy Rating and Favorable NPV Outlook
PremiumRatings
Cullinan Oncology: FDA Acceptance of Zipalertinib NDA and Upcoming CLN-978 Data Underpin Buy Rating and Favorable NPV Outlook
2M ago
CGEM
Cullinan Therapeutics price target raised to $30 from $27 at H.C. Wainwright
PremiumThe Fly
Cullinan Therapeutics price target raised to $30 from $27 at H.C. Wainwright
2M ago
CGEM
Cullinan Therapeutics announces U.S. FDA accepted NDA for zipalertinib
PremiumThe Fly
Cullinan Therapeutics announces U.S. FDA accepted NDA for zipalertinib
2M ago
CGEM
Clear Street says Gilead-Ouro deal highlights upside for Cullinan’s velinotamig
PremiumThe FlyClear Street says Gilead-Ouro deal highlights upside for Cullinan’s velinotamig
3M ago
CGEM
GILD
Cullinan Therapeutics price target raised to $36 from $34 at Wedbush
Premium
The Fly
Cullinan Therapeutics price target raised to $36 from $34 at Wedbush
4M ago
CGEM
Cullinan: Advancing Immunology and Oncology Pipeline Undervalued; Buy Rating on CLN-978 Catalysts and Strong Cash Runway
Premium
Ratings
Cullinan: Advancing Immunology and Oncology Pipeline Undervalued; Buy Rating on CLN-978 Catalysts and Strong Cash Runway
4M ago
CGEM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >